Product Code: A00574
The global capsule endoscopy system market was valued at $616.57 million in 2020, and is projected to reach $2.0 billion by 2030, growing at a CAGR of 12.4% from 2021 to 2030.
Capsule endoscopes are tiny wireless endoscopic systems that capture images of the body's interior. The endoscopic camera is small enough to fit in a vitamin capsule and can capture hundreds of images, which are subsequently sent to the recorder. Physicians can use capsule endoscopes to acquire images of parts of the body that a regular endoscope cannot reach. It is a technique used for the diagnosis and monitoring of gastrointestinal disorders, including small bowel diseases, colonic diseases, and esophageal diseases using wireless video capsule, data recorder, software, and workstations
Major factors that drive the growth of the global capsule endoscopy systems market include rise demand for minimally invasive diagnostic procedures, increase in prevalence of cancer, growth in geriatric population, and surge in introduction of technologically advanced capsules. However, high cost of treatments and endoscopy equipment, limited reimbursement, and the risk of retention of the capsule may require endoscopic retrieval or rarely surgical resection restrain the market growth. Conversely, many innovative and technologically advanced products gain commercialization during the forecast period, owing to increase in R&D activities of key market players.
The global capsule endoscopy systems market is segmented on the basis of component, disease, and region. According to component, it is divided into capsule endoscopes and recorders & workstations. Depending on disease, it is divided into small intestine disorder, esophageal disorder, and colonic disorder. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include: Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd., RF System lab, CapsoVision, Shengxian Minimal Invasive Inc., Check -Cap, Accuread Endoscopy Inc., Fujifilm Holding Corporation, and Anhan Technology (wuhan) co., Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the capsule endoscopy system market analysis from 2020 to 2030 to identify the prevailing capsule endoscopy system market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the capsule endoscopy system market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global capsule endoscopy system market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Component
- Capsule Endoscope
- Work stations and recorders
By Disease Type
- Small Intestine Disorder
- Esophageal disorder
- Colonic disorder
By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Olympus Corporation
- CapsoVision Inc.
- Chongqing Jinshan Science and Technology Group Co.
- IntroMedic Co.
- RF Systems Lab
- Shangxian Minimal Invasive Inc.
- MEDTRONIC PLC.
- Fujifilm Holding Corporation
- Check Cap
- Anx Robotica
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Capsule Endoscope
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Work stations and recorders
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Small Intestine Disorder
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Esophageal disorder
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Colonic disorder
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
CHAPTER 6: CAPSULE ENDOSCOPY SYSTEM MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Component
- 6.2.3 North America Market size and forecast, by Disease Type
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Component
- 6.2.4.1.2 Market size and forecast, by Disease Type
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Component
- 6.2.4.2.2 Market size and forecast, by Disease Type
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Component
- 6.2.4.3.2 Market size and forecast, by Disease Type
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Component
- 6.3.3 Europe Market size and forecast, by Disease Type
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Component
- 6.3.4.1.2 Market size and forecast, by Disease Type
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Component
- 6.3.4.2.2 Market size and forecast, by Disease Type
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Component
- 6.3.4.3.2 Market size and forecast, by Disease Type
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Component
- 6.3.4.4.2 Market size and forecast, by Disease Type
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Component
- 6.3.4.5.2 Market size and forecast, by Disease Type
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Component
- 6.3.4.6.2 Market size and forecast, by Disease Type
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Component
- 6.4.3 Asia-Pacific Market size and forecast, by Disease Type
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Component
- 6.4.4.1.2 Market size and forecast, by Disease Type
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Component
- 6.4.4.2.2 Market size and forecast, by Disease Type
- 6.4.4.3 India
- 6.4.4.3.1 Market size and forecast, by Component
- 6.4.4.3.2 Market size and forecast, by Disease Type
- 6.4.4.4 Australia
- 6.4.4.4.1 Market size and forecast, by Component
- 6.4.4.4.2 Market size and forecast, by Disease Type
- 6.4.4.5 South Korea
- 6.4.4.5.1 Market size and forecast, by Component
- 6.4.4.5.2 Market size and forecast, by Disease Type
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Component
- 6.4.4.6.2 Market size and forecast, by Disease Type
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Component
- 6.5.3 LAMEA Market size and forecast, by Disease Type
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Component
- 6.5.4.1.2 Market size and forecast, by Disease Type
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Component
- 6.5.4.2.2 Market size and forecast, by Disease Type
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Component
- 6.5.4.3.2 Market size and forecast, by Disease Type
- 6.5.4.4 Rest of LAMEA
- 6.5.4.4.1 Market size and forecast, by Component
- 6.5.4.4.2 Market size and forecast, by Disease Type
CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
CHAPTER 8: COMPANY PROFILES
- 8.1 Olympus Corporation
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 CapsoVision Inc.
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Chongqing Jinshan Science and Technology Group Co.
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 IntroMedic Co.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 RF Systems Lab
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Shangxian Minimal Invasive Inc.
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 MEDTRONIC PLC.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Fujifilm Holding Corporation
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Check Cap
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Anx Robotica
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments